Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Biosafety (1)
- Cannabis (1)
- Cartagena Protocol (1)
- Drug legalization (1)
- Drug trials (1)
-
- GMO (1)
- Globalization (1)
- India (1)
- Marijuana (1)
- Outsourcing (1)
- Pharmaceutical research (1)
- Treaty Establishing the European Economic Community; free movement of goods; protection of life or health; Court of Justice of the European Community; European Communities v. Federal Republic of Germany; beer purity laws (1)
Articles 1 - 4 of 4
Full-Text Articles in Food and Drug Law
"Hash"Ing Out Inequality In The Legal Recreational Cannabis Industry, Maya Rahwanji
"Hash"Ing Out Inequality In The Legal Recreational Cannabis Industry, Maya Rahwanji
Northwestern Journal of International Law & Business
No abstract provided.
Outsourcing Drug Investigations To India: A Comment On U.S., Indian, And International Regulation Of Clinical Trials In Cross-Border Pharmaceutical Research, James Cekola
Northwestern Journal of International Law & Business
The traditional research and development model of large pharmaceutical companies is arguably unsustainable in current times. For example, estimated research and development costs increased as much as twelve percent over the last year while pharmaceutical sales grew only seven percent over the same period. Current estimates put the price to develop a new drug and bring it to market between $800 million and $1.5 billion per drug. These costs are increasing, driving large pharmaceutical companies to find more cost-effective research and development models. One cost-saving initiative is to globalize the system. In particular, companies have increasingly outsourced the required investigational …
Merits Of Ratifying And Implementing The Cartagena Protocol On Biosafety, Jonathan A. Glass
Merits Of Ratifying And Implementing The Cartagena Protocol On Biosafety, Jonathan A. Glass
Northwestern Journal of International Law & Business
In a meeting in Cartagena, Colombia in February 1999, parties to the CBD, known as the Conference of the Parties ("COP"), could not agree on the proposed biosafety protocol drafted in prior meetings.3 However, in January 2000, in a meeting in Montreal, the parties to the CBD finally adopted the draft protocol, naming it the Cartagena Protocol on Biosafety ("Cartagena Protocol or Protocol"). 4 When the Cartagena Protocol opened for signature at the CBD's COP meeting in Nairobi in May 2000, sixty-four governments and the European Union signed the Protocol . Presently, eighty-one parties have signed the Protocol, while only …
Commission V. Germany And Article 36 Protection Of Human Life And Health, Mimi Y. Lee
Commission V. Germany And Article 36 Protection Of Human Life And Health, Mimi Y. Lee
Northwestern Journal of International Law & Business
Free movement of goods is a fundamental principle of the European Community. Article 36 of the EEC Treaty, however, provides important exceptions to the principle of free movement of goods as embodied in Article 30. Recently, the Court of Justice of the European Community ("Court of Justice" or "Court") has begun to develop a significant body of case law on the protection of human health exception of Article 36. This development coincides with the increasing public interest in consumer protection law, particularly with regard to the production of food-stuffs. Commission of the European Communities v. Federal Republic of Germany presents …